Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

ZULIMONT

Class 5Status: Accepted & Advertised
Application Number6001934
Trademark Status
Accepted & Advertised
Trademark Class5
Application Date2023-06-30
Proprietor NamePFERD PHARMACEUTICAL PVT. LTD.
Appropriate OfficeKOLKATA
StateORISSA
Trademark TypeWORD
User DetailsProposed to be used
Agent NameS.SINGH & ASSOCIATES[3536]
Agent AddressB-1, 2ND FLOOR, DERAWAL NAGAR, DELHI - 110009
Goods And Services Details[CLASS : 5] Medicinal and pharmaceutical preparations

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
ZULIMONT5Accepted & Advertised
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about ZULIMONT.

What is the status of trademark application 6001934?
The current status of trademark application 6001934 for ZULIMONT is Accepted & Advertised.
What is the trademark class of ZULIMONT?
ZULIMONT is registered under trademark class 5.
Who is the proprietor of ZULIMONT?
The proprietor of ZULIMONT is PFERD PHARMACEUTICAL PVT. LTD..
When was trademark application 6001934 filed?
Trademark application 6001934 for ZULIMONT was filed on 2023-06-30.